Sanford E. Perl, P.C.

Kirkland & Ellis is advising private equity firm GTCR on the proposed $180 million acquisition of Cloudbreak Health, LLC, a leading provider of tech-enabled, healthcare-focused language interpretation services. The definitive agreement was announced on November 16, 2023. Cloudbreak is being carved out of UpHealth Inc (NYSE: UPH). The deal is expected to close in the first quarter of 2024 following customary regulatory and stockholder approvals and closing conditions. Cloudbreak’s core offering is Martti™ (My Accessible Real-Time Trusted Interpreter), a HIPAA-compliant Video Remote Interpretation solution that connects patients with interpreters in over 250 languages across its network of more than 1,000 interpreters. Read the transaction press release The Kirkland team is being led by corporate partners Dan Guerin and Neil Vohra and restructuring partners Ross Kwasteniet and Chris Koenig and includes corporate associates Ben Vizvary, Jack Silverman and Dan O’Dea, with support from corporate partners Rachael Coffey, Sanford Perl and Michael Weed; restructuring associate Aaron Metviner; technology & IP transactions partners Aaron Lorber and Bernadette Coppola; capital markets partners Bob Goedert and Kevin Frank; debt finance partner Tom Dobleman and associate Tasha Serafin; and tax partners Michael Carew and Polina Liberman.

Nov 17

1 min

Kirkland & Ellis advised Insignia Capital Group on its definitive agreement to sell its majority interest in its portfolio company, WillowTree, to TELUS International (NYSE and TSX: TIXT) for a total enterprise value of US$1.225 billion. The deal is anticipated to close in January 2023, and is subject to customary closing conditions and regulatory approvals. Founded in 2008 and headquartered in Charlottesville, Virginia, WillowTree is a digital product consultancy that provides end-to-end, strategy, design, full-stack development and growth marketing services to the world's leading brands. Read the Insignia Capital Group press release The Kirkland team was led by corporate partners Sanford Perl, Robert Wilson and Melanie Harmon and associates Gardner Bell, Elizabeth Garai, Gino Jacobazzi, Lauren Fiotakis and Griffin Clark, tax partner Kevin Coenen and associate Katherine Karnosh, and capital markets partners Michael Keeley and Cot Eversole and associate Justin Hay.

Oct 27

1 min

Kirkland & Ellis advised GTCR and its portfolio company RevSpring, Inc. on its sale to healthcare-focused investment firm Frazier Healthcare Partners. RevSpring is a leading provider of end-to-end communication and payment solutions in healthcare and financial services, sending 1.5 billion communications and processing more than $8 billion in payment volume annually for its healthcare and financial services customers. The transaction was announced March 12, 2024. Read RevSpring’s press release The Kirkland team was led by corporate partners Neil K. Vohra and Mark Fennell and included corporate associates Jessica Lowe, Paul Koltz, with support from corporate partner Sanford Perl and associates Brian Arnfelt and Francesco Castaldi; debt finance partners Tom Dobleman and Patrick Loughery and associate Alex Straka; and tax partners Polina Liberman and Michael Alcan.

Mar 12

1 min

Kirkland & Ellis advised private equity firm GTCR in a new partnership in which funds managed by Blackstone’s GP Stakes business will acquire a minority ownership interest in GTCR. Blackstone’s GP Stakes business specializes in value-added, long-term partnerships with leading private-market alternative asset management firms. Terms of the transaction were not disclosed. Read the GTCR press release The Kirkland team was led by transactional partners Daniel Lavon-Krein, Michael Reeves, Sanford Perl and Stephen Ritchie and tax partner Dan Meehan; and included investment funds partners Sean Malone and Tana Wilner and associates Christopher Urruela Stauss, Steven Robles and Tarah Perkins; tax partner Alec Campbell and associate Brandon Short; investment funds regulatory partners Norm Champ and Alpa Patel and associate Christopher Pristouris; and employee benefits partner Liz Dyer.

Jul 27

1 min

Kirkland & Ellis advised GTCR, a leading private equity firm, and its portfolio company, Resonetics, on the sale of a minority equity stake in Resonetics to funds affiliated with global investment firm Carlyle (NASDAQ: CG), valuing Resonetics at approximately $2.25 billion. Carlyle will join GTCR as a meaningful shareholder in Resonetics as a result of the transaction. Read the GTCR press release The Kirkland team was led by corporate partners Christopher Thomas, Michael Weed and Sanford Perl and associate Daniella Vespoli.

Dec 3

1 min